Some patients are at higher risk for recurrent cardiovascular events following a myocardial infarction, due to their clinical characteristics and comorbidities. Still, they are less often treated with guideline-recommended therapies. We examined more than a decade long trends in the treatment and outcome of patients with myocardial infarction according to the risk for recurrent cardiovascular events, using the TIMI risk score for secondary prevention.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023